• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Screening of Living Kidney Donors for Genetic Diseases: Commentary.

作者信息

Steiner Robert W

机构信息

UCSD Center for Transplantation and Division of Nephrology, University of California at San Diego School of Medicine, San Diego, California.

出版信息

Kidney360. 2024 Oct 1;5(10):1419-1421. doi: 10.34067/KID.0000000000000470. Epub 2024 May 15.

DOI:10.34067/KID.0000000000000470
PMID:38748489
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11556911/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/84c5/11556911/d06a87a86a00/kidney360-5-1419-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/84c5/11556911/d06a87a86a00/kidney360-5-1419-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/84c5/11556911/d06a87a86a00/kidney360-5-1419-g001.jpg

相似文献

1
Screening of Living Kidney Donors for Genetic Diseases: Commentary.活体肾供体的遗传病筛查：评论
Kidney360. 2024 Oct 1;5(10):1419-1421. doi: 10.34067/KID.0000000000000470. Epub 2024 May 15.
2
Screening and follow-up of living kidney donors: a systematic review of clinical practice guidelines.活体肾捐献者的筛查和随访：临床实践指南的系统评价。
Transplantation. 2011 Nov 15;92(9):962-72. doi: 10.1097/TP.0b013e3182328276.
3
Utility of Genetic Information for Management in Kidney Transplantation and Living Donation.基因信息在肾移植和活体供肾管理中的应用价值。
Semin Nephrol. 2025 Jul;45(4):151658. doi: 10.1016/j.semnephrol.2025.151658. Epub 2025 Jul 17.
4
Cardiovascular and kidney outcomes of living kidney donors with preexisting hypertension: A systematic review and meta-analysis.患有高血压的活体肾供者的心血管和肾脏结局：一项系统评价和荟萃分析。
Am J Hypertens. 2025 Jun 26. doi: 10.1093/ajh/hpaf114.
5
Metabolic risk after living kidney donation: an analysis of the Swiss Organ Living-Donor Health Registry.活体肾捐献后的代谢风险：瑞士器官活体捐献者健康登记处的分析
Swiss Med Wkly. 2025 Jun 27;155:4513. doi: 10.57187/s.4513.
6
The Course and Predictors of Health-Related Quality of Life in Living Kidney Donors: A Systematic Review and Meta-Analysis.活体肾供体健康相关生活质量的病程及预测因素：一项系统评价与荟萃分析
Am J Transplant. 2015 Dec;15(12):3041-54. doi: 10.1111/ajt.13453. Epub 2015 Sep 28.
7
Genetic testing in the evaluation of recipient candidates and living kidney donors.遗传检测在受者候选人和活体供肾者评估中的应用。
Curr Opin Nephrol Hypertens. 2024 Jan 1;33(1):4-12. doi: 10.1097/MNH.0000000000000934. Epub 2023 Oct 12.
8
The direct and indirect economic costs incurred by living kidney donors-a systematic review.活体肾供者产生的直接和间接经济成本——一项系统综述
Nephrol Dial Transplant. 2006 Jul;21(7):1952-60. doi: 10.1093/ndt/gfl069. Epub 2006 Mar 22.
9
Contextual factors of implementing APOL1 genetic testing into living kidney donor clinical evaluation.将APOL1基因检测纳入活体肾供体临床评估的背景因素。
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2025 Jun 11. doi: 10.1007/s00103-025-04068-8.
10
Robotic versus laparoscopic versus open nephrectomy for live kidney donors.机器人辅助与腹腔镜辅助与开放性肾切除术用于活体供肾者。
Cochrane Database Syst Rev. 2024 May 9;5(5):CD006124. doi: 10.1002/14651858.CD006124.pub3.

本文引用的文献

1
Screening of Living Kidney Donors for Genetic Diseases: PRO.活体肾供体遗传性疾病筛查：支持观点。
Kidney360. 2024 Oct 1;5(10):1416-1418. doi: 10.34067/KID.0000000000000350. Epub 2024 May 15.
2
Screening of Living Kidney Donors for Genetic Diseases: CON.活体肾供体遗传性疾病筛查：反对意见
Kidney360. 2024 Oct 1;5(10):1413-1415. doi: 10.34067/KID.0000000000000353. Epub 2024 May 15.
3
Heeding the Increased Exponential Accumulation of ESRD After Living Kidney Donation.关注活体肾移植后终末期肾病指数的快速增长。
Transplantation. 2024 Apr 1;108(4):836-838. doi: 10.1097/TP.0000000000004705. Epub 2023 Jul 19.
4
Genetic evaluation of living kidney donor candidates: A review and recommendations for best practices.活体肾捐献者候选人的遗传学评估：综述及最佳实践建议。
Am J Transplant. 2023 May;23(5):597-607. doi: 10.1016/j.ajt.2023.02.020. Epub 2023 Mar 1.
5
"You can't get there from here": Critical obstacles to current estimates of the ESRD risks of young living kidney donors.“从这里无法到达那里”：当前对年轻活体肾脏捐献者的 ESRD 风险评估的关键障碍。
Am J Transplant. 2019 Jan;19(1):32-36. doi: 10.1111/ajt.15089. Epub 2018 Oct 3.
6
Evaluation of Potential Living Kidney Donors in the Era.评估当代潜在活体肾供者。
J Am Soc Nephrol. 2018 Apr;29(4):1079-1081. doi: 10.1681/ASN.2018020137. Epub 2018 Mar 9.
7
Quantifying Postdonation Risk of ESRD in Living Kidney Donors.量化活体肾供者捐献后发生终末期肾病的风险。
J Am Soc Nephrol. 2017 Sep;28(9):2749-2755. doi: 10.1681/ASN.2016101084. Epub 2017 Apr 27.
8
Risk of end-stage renal disease following live kidney donation.活体肾捐献后终末期肾病的风险。
JAMA. 2014 Feb 12;311(6):579-86. doi: 10.1001/jama.2013.285141.
9
Shared decision making: a model for clinical practice.共同决策：一种临床实践模式。
J Gen Intern Med. 2012 Oct;27(10):1361-7. doi: 10.1007/s11606-012-2077-6. Epub 2012 May 23.